Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.
Back to dashboard
Company Information
About this company
Key people
Albert Bourla
Chairman of the Board, Chief Executive Officer
Chris Boshoff
Chief Scientific Officer, President - Research & Development
Shantanu Narayen
Lead Independent Director
Ronald E. Blaylock
Independent Director
Mortimer J. Buckley
Independent Director
Susan Desmond-Hellmann
Independent Director
Joseph J. Echevarria
Independent Director
Cecile Guegan
Interim Chief Financial Officer
Payal Sahni
Executive Vice President, Chief People Experience Officer
Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Andrew Baum
Executive Vice President, Chief Strategy and Innovation Officer
Alexandre de Germay
Executive Vice President, Chief International Commercial Officer
Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Aamir Malik
Executive Vice President, Chief U.S. Commercial Officer
Michael Mcdermott
Executive Vice President, Chief Global Supply and Quality Officer
Click to see more
Key facts
- Shares in issue9.64bn
- EPICPFE
- ISINUS7170811035
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$168.60bn
- Employees75,000
- ExchangeNew York Stock Exchange
- IndexS&P 500, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.